Multiple organ failure after an overdose of less than 0.4 mg/kg of colchicine: role of coingestants and drugs during intensive care management

被引:24
作者
Montiel, Virginie [1 ]
Huberlant, Vincent [1 ]
Vincent, Marie-Francoise [2 ]
Bonbled, Frederic [3 ]
Hantson, Philippe [1 ]
机构
[1] Catholic Univ Louvain, Dept Intens Care, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Biochem Lab, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, Dept Pathol, B-1200 Brussels, Belgium
关键词
Colchicine poisoning; Atorvastatin; Rhabdomyolysis; Hypertriglyceridemia; Hyperammonemia; Cholestatic liver failure; Propofol infusion syndrome; METABOLISM; TOXICOLOGY;
D O I
10.3109/15563650.2010.509101
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Introduction. Although the ingestion of a dose of colchicine lower than 0.5 mg/kg is usually complicated by a mortality rate less than 5%, severe complications may be associated with drug-drug interactions in case of overdose combining other drugs. Case report. A 33-year-old previously healthy woman was admitted after a drug overdose combining colchicine, atorvastatin, ibuprofen, diclofenac, and furosemide. The amount of colchicine ingested was exactly 20 mg, corresponding to 0.33 mg/kg. Despite this relatively low dose, she presented the clinical course that is usually seen with much larger colchicine ingestions. She developed acute renal and liver failure, acute lung injury, pancytopenia with sepsis, rhabdomyolysis, hypertriglyceridemia, and ultimately died on Day 14 from hyperammonemic encephalopathy, refractory hypoxemia, and cardiac arrhythmias. Discussion. Serious drug-drug interactions may have complicated colchicine poisoning. In particular, atorvastatin, an inhibitor of P-glycoprotein and cytochrome P450 3A4, was likely responsible for an increased severity of rhabdomyolysis. In addition, propofol used for sedation during mechanical ventilation may have induced symptoms consistent with "propofol infusion syndrome," with further muscular injury and hypertriglyceridemia. The mechanism of death was unusual and similar to Reye's syndrome.</.
引用
收藏
页码:845 / 848
页数:4
相关论文
共 13 条
[1]  
BISMUTH C, 1986, J TOXICOL CLIN EXPER, V6, P33
[2]   Markedly altered colchicine kinetics in a fatal intoxication: Examination of contributing factors [J].
Borron, SW ;
Scherrmann, JM ;
Baud, FJ .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1996, 15 (11) :885-890
[3]   Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin [J].
Francis, Lisa ;
Bonilla, Eduardo ;
Soforo, Ekaterina ;
Neupane, Hom ;
Nakhla, Hassan ;
Fuller, Christine ;
Perl, Andras .
CLINICAL RHEUMATOLOGY, 2008, 27 (01) :129-131
[4]   Role of P-glycoprotein in statin drug interactions [J].
Holtzman, Carol W. ;
Wiggins, Barbara S. ;
Spinler, Sarah A. .
PHARMACOTHERAPY, 2006, 26 (11) :1601-1607
[5]   Statin safety: A systematic review [J].
Law, M ;
Rudnicka, AR .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (8A) :52C-60C
[6]  
Park JE, 2008, XENOBIOTICA, V38, P1240, DOI [10.1080/00498250802334391, 10.1080/00498250802334391 ]
[7]   Reye's and Reye's-like syndromes [J].
Pugliese, Agostino ;
Beltramo, Tiziana ;
Torre, Donato .
CELL BIOCHEMISTRY AND FUNCTION, 2008, 26 (07) :741-746
[8]   The metabolism of diclofenac - Enzymology and toxicology perspectives [J].
Tang, W .
CURRENT DRUG METABOLISM, 2003, 4 (04) :319-329
[9]   Colchicine biotransformation by human liver microsomes - Identification of CYP3A4 as the major isoform responsible for colchicine demethylation [J].
Tateishi, T ;
Soucek, P ;
Caraco, Y ;
Guengerich, FP ;
Wood, AJJ .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (01) :111-116
[10]   Colchicine Update: 2008 [J].
Terkeltaub, Robert A. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2009, 38 (06) :411-419